Latest news with #ArgenxSe
Business Insider
07-07-2025
- Business
- Business Insider
Goldman Sachs Remains a Buy on Argenx Se (ARGX)
In a report released on July 4, Richard Felton from Goldman Sachs maintained a Buy rating on Argenx Se, with a price target of $835.00. The company's shares closed last Thursday at $543.48. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Felton is a 4-star analyst with an average return of 10.2% and a 64.84% success rate. Felton covers the Healthcare sector, focusing on stocks such as Carl Zeiss Meditec, Fresenius Medical Care AG & Co. KGaA, and Fresenius SE & Co. KGaA. Argenx Se has an analyst consensus of Strong Buy, with a price target consensus of $754.09, a 38.75% upside from current levels. In a report released on July 2, Morgan Stanley also initiated coverage with a Buy rating on the stock with a $700.00 price target.
Business Insider
17-05-2025
- Business
- Business Insider
H.C. Wainwright Reaffirms Their Buy Rating on Argenx Se (ARGX)
In a report released on May 15, Douglas Tsao from H.C. Wainwright maintained a Buy rating on Argenx Se (ARGX – Research Report), with a price target of $720.00. The company's shares closed yesterday at $565.63. Confident Investing Starts Here: Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter Tsao covers the Healthcare sector, focusing on stocks such as Protagonist Therapeutics, Argenx Se, and scPharmaceuticals. According to TipRanks, Tsao has an average return of 6.8% and a 36.71% success rate on recommended stocks. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Argenx Se with a $749.93 average price target, representing a 32.58% upside. In a report released on May 15, Stifel Nicolaus also maintained a Buy rating on the stock with a $780.00 price target. The company has a one-year high of $678.21 and a one-year low of $356.38. Currently, Argenx Se has an average volume of 412.5K.
